Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Leukemia, Myeloid, Acute 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Myelodysplastic Syndromes 41Leukemia, Lymphocytic, Chronic, B-Cell 30Lymphoma, Non-Hodgkin 27Multiple Myeloma 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hodgkin Disease 20Leukemia 17Myeloproliferative Disorders 16Recurrence 15Melanoma 15Lymphoma, Follicular 15Leukemia, Biphenotypic, Acute 15Lymphoma, Mantle-Cell 14Lymphoma 14Leukemia, Myelomonocytic, Chronic 14Lymphoma, Large B-Cell, Diffuse 13Hematologic Neoplasms 13Burkitt Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Lymphoma, B-Cell, Marginal Zone 10Lymphoma, B-Cell 10Primary Myelofibrosis 8Neoplasm, Residual 7Neoplasm Metastasis 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Neoplasms 6Graft vs Host Disease 6

Interventions

AZD 6244 12trametinib 4mirdametinib 2fludarabine 2Lasers, Solid-State 2Inhalation 2Deoxycholic Acid 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1omipalisib 1lorlatinib 1fludarabine phosphate 1encorafenib 1dabrafenib 1cabozantinib 1binimetinib 1abemaciclib 1Waiting Lists 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Radiation 1Polidocanol 1N-monoacetylcystine 1Melphalan 1Magnetic Resonance Spectroscopy 1Lovastatin 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × fludarabine phosphate × 1 year × Clear all
NCT05849662 2026-04-15

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Recruiting
58 enrolled
CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡